Clinical trial
Resonance Breathing Opioid Use Disorder
NCT05830773 is registered in ClinicalTrials.gov with University of Texas at Austin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Resonance Breathing Opioid Use Disorder
- Lead sponsor
- University of Texas at Austin
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 9, 2021
- Completion date
- August 31, 2023
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.